Clinical Trial

A Clinical Study of AK0610

Name: A Clinical Study of AK0610 — clinical trial record (NCT06996704)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated May 30, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.

Summary

The study consists of two parts: dose escalation and expansion. It includes five cohorts in the dose-escalation phase and two expansion cohorts based on pharmacokinetic data.

Trial Details

NCT Number	NCT06996704
Lead Sponsor	Shanghai Ark Biopharmaceutical Co., Ltd.
Conditions	Healthy Volunteer Study
Enrollment	136 participants
Start Date	2024-02-29
Primary Completion	2025-06 (estimated)
Study Completion	2025-09 (estimated)
Updated on ClinicalTrials.gov	2025-05-30